Cresset Asset Management’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
– Sell
-4,083
Closed -$311K – 1611
2025
Q1
$311K Sell
4,083
-132
-3% -$10.1K ﹤0.01% 1287
2024
Q4
$291K Buy
4,215
+97
+2% +$6.99K ﹤0.01% 1366
2024
Q3
$301K Buy
4,118
+916
+29% +$67.6K ﹤0.01% 1798
2024
Q2
$215K Buy
+3,202
New +$124K ﹤0.01% 1867
2019
Q2
– Sell
-28
Closed -$1K – 1039
2019
Q1
$1K Hold
28
– – ﹤0.01% 1808
2018
Q4
$0 Buy
+28
New +$447 ﹤0.01% 1723

Other funds holding INSM

Cresset Asset Management's INSM Position: Q2 2025 in Review

Cresset Asset Management sold out of Insmed (INSM) in Q2 2025, closing a stake of 4,083 shares — an estimated $311K sold.

Cresset Asset Management first reported a position in INSM in Q4 2018 and held it in 6 quarters. The position peaked at $311K in Q1 2025. 516 funds tracked by Wall St. Rank hold INSM as of Q2 2025.

  • Cresset Asset Management reported no remaining Insmed position as of Q2 2025 after selling out during the quarter.
  • Cresset Asset Management sold 4,083 Insmed shares in Q2 2025, an estimated $311K.
  • Cresset Asset Management first reported a position in Insmed in Q4 2018 and held it in 6 quarters.
  • Cresset Asset Management's Insmed position peaked at $311K in Q1 2025.
  • 516 funds tracked by Wall St. Rank held Insmed as of Q2 2025.

Based on Cresset Asset Management's 13F filing for Q2 2025, filed 13 Aug 2025.